CL2014002236A1 - Anticuerpos recombinantes con especificidad dual por gangliósidos n-acetil gm3 y n-glicolil gm3 y su uso. - Google Patents

Anticuerpos recombinantes con especificidad dual por gangliósidos n-acetil gm3 y n-glicolil gm3 y su uso.

Info

Publication number
CL2014002236A1
CL2014002236A1 CL2014002236A CL2014002236A CL2014002236A1 CL 2014002236 A1 CL2014002236 A1 CL 2014002236A1 CL 2014002236 A CL2014002236 A CL 2014002236A CL 2014002236 A CL2014002236 A CL 2014002236A CL 2014002236 A1 CL2014002236 A1 CL 2014002236A1
Authority
CL
Chile
Prior art keywords
glycolyl
gangliosides
acetyl
recombinant antibodies
dual specificity
Prior art date
Application number
CL2014002236A
Other languages
English (en)
Inventor
Frias Ernesto Moreno
Dorantes Gertrudis Rojas
Pazos Ana Victoria Casadesus
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48039960&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014002236(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Publication of CL2014002236A1 publication Critical patent/CL2014002236A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • C07K16/3084—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CL2014002236A 2012-03-01 2014-08-22 Anticuerpos recombinantes con especificidad dual por gangliósidos n-acetil gm3 y n-glicolil gm3 y su uso. CL2014002236A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20120035A CU24120B1 (es) 2012-03-01 2012-03-01 Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3

Publications (1)

Publication Number Publication Date
CL2014002236A1 true CL2014002236A1 (es) 2014-12-05

Family

ID=48039960

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002236A CL2014002236A1 (es) 2012-03-01 2014-08-22 Anticuerpos recombinantes con especificidad dual por gangliósidos n-acetil gm3 y n-glicolil gm3 y su uso.

Country Status (22)

Country Link
US (1) US9527920B2 (es)
EP (1) EP2821417A2 (es)
JP (1) JP5933044B2 (es)
KR (1) KR20140126349A (es)
CN (1) CN104136463B (es)
AR (1) AR090207A1 (es)
AU (1) AU2013225453A1 (es)
CA (1) CA2865050A1 (es)
CL (1) CL2014002236A1 (es)
CO (1) CO7051011A2 (es)
CU (1) CU24120B1 (es)
EA (1) EA201491618A1 (es)
HK (1) HK1198654A1 (es)
IL (1) IL234394A0 (es)
MX (1) MX2014010456A (es)
PE (1) PE20142277A1 (es)
PH (1) PH12014501950A1 (es)
SG (1) SG11201405151YA (es)
TN (1) TN2014000330A1 (es)
TW (1) TW201348259A (es)
WO (1) WO2013127373A2 (es)
ZA (1) ZA201407043B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU24120B1 (es) * 2012-03-01 2015-08-27 Ct De Inmunología Molecular Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3
CN104651314B (zh) * 2015-02-14 2018-06-19 百泰生物药业有限公司 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子
WO2016156468A1 (en) * 2015-03-31 2016-10-06 Vhsquared Limited Polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4107154A1 (de) 1990-10-11 1992-04-16 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen melanom
CU22731A1 (es) 1998-02-05 2002-02-28 Centro Inmunologia Molecular Anticuerpo monoclonal que reconoce el oligosacárido ácido siálico n´glicolilado-galactosa-glucosa (ngcneu-gal-glu) en tumores malignos y composiciones farmacéuticas que los contienen
CU23403A1 (es) 2003-04-23 2009-08-04 Centro Inmunologia Molecular Anticuerpos recombinantes y fragmentos que reconocen el gangliósido n-glicolil gm3 y su uso para diagnóstico y tratamiento de tumores
CU24120B1 (es) * 2012-03-01 2015-08-27 Ct De Inmunología Molecular Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3

Also Published As

Publication number Publication date
KR20140126349A (ko) 2014-10-30
WO2013127373A2 (es) 2013-09-06
WO2013127373A3 (es) 2013-10-31
PH12014501950A1 (en) 2014-11-24
AR090207A1 (es) 2014-10-29
EP2821417A2 (en) 2015-01-07
CN104136463B (zh) 2016-08-24
JP5933044B2 (ja) 2016-06-08
PE20142277A1 (es) 2015-01-15
ZA201407043B (en) 2015-12-23
MX2014010456A (es) 2014-10-13
CU24120B1 (es) 2015-08-27
AU2013225453A1 (en) 2014-09-25
JP2015516367A (ja) 2015-06-11
US9527920B2 (en) 2016-12-27
CN104136463A (zh) 2014-11-05
CU20120035A7 (es) 2013-10-29
HK1198654A1 (en) 2015-05-22
US20150093385A1 (en) 2015-04-02
CO7051011A2 (es) 2014-09-10
CA2865050A1 (en) 2013-09-06
TN2014000330A1 (en) 2015-12-21
TW201348259A (zh) 2013-12-01
EA201491618A1 (ru) 2014-12-30
EP2821417A9 (en) 2015-04-01
IL234394A0 (en) 2014-10-30
SG11201405151YA (en) 2014-10-30

Similar Documents

Publication Publication Date Title
DK3346008T3 (da) Rekombinante mikroorganismer og anvendelser deraf
ME03512B (me) Cd47 antitijela i postupci za njihovu upotrebu
BR112014024373A2 (pt) anticorpos regulados por protease
EP2889276A4 (en) REINFORCED GLASS
PT3199552T (pt) Anticorpos anti-ceacam5 e suas utilizações
DK4389885T3 (da) Alfa-amylasevarianter
EP2674405A4 (en) INTERMEDIATE LAYER FOR COMPOSITE GLASS AND COMPOSITE GLASS
BR112014012137A2 (pt) anticorpos anti-fgfr2 e suas utilizações
PT2906421T (pt) Envidraçado laminado.
BR112013029782A2 (pt) copo de bebida e conjunto de copo de bebida
BR112014024675A8 (pt) célula hospedeira recombinante, cultura celular
EP2848595A4 (en) COMPOSITE GLASS
IL238227A0 (en) Anti-c16orf54 antibodies and methods of use thereof
BR112014025037A2 (pt) anticorpo ou um fragmento funcional do mesmo, nucleotídeo, vetor recombinante, célula, métodos para a produção de um anticorpo ou fragmento funcional, para detecção ou ensaio de fgfr2 humano iiib, para a identificação de um indivíduo receptor de uma composição farmacêutica, e, para identificar e para produzir uma substância, forma modificada, composição, e, reagente
EP2879794A4 (en) CELL CULTURE
BR112014024484A2 (pt) interação com serviço confiável
EP2743172A4 (en) TANK SUPPORT STRUCTURE AND FLOATING CONSTRUCTION
CL2014002030A1 (es) Alfa-amilasa
FR2988733B1 (fr) Microorganisme recombinant
DK2938486T3 (da) Kompositglas
BR112014002624A2 (pt) microorganismo recombinante e cultura de microorganismo recombinante
IL229315B (en) Chaperone interaction assays and uses thereof
GB201219487D0 (en) Anti-S100A4 antibody molecules and their uses
DK3431504T3 (da) Antiphospholipase d4-antistof
ES1075683Y (es) Tarjeta de visita con llamador incorporado